Ronggui Lin
Impact in
-
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Chemokine receptors and signaling
-
- Immunotherapy and Immune Responses
Papers in
- Co-authors
- Heguang Huang (21 shared papers)Xianchao Lin (23 shared papers)Fengchun Lu (21 shared papers)Yu Pan (4 shared papers)Fei Chen (1 shared paper)Wen Shi (1 shared paper)Yuanyuan Yang (8 shared papers)Yuanyuan Zhou (1 shared paper)
- Journals
- Langenbeck s Archives of Surgery (3 papers)Cancer Letters (2 papers)BMC Surgery (2 papers)World Journal of Surgical Oncology (2 papers)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ronggui Lin
31 papers receiving 270 citations
Peers
Comparison fields: 5 of 56
- Oncology 111
- Immunology 51
- Neurology 16
- Surgery 71
- Gastroenterology 7
Countries citing papers authored by Ronggui Lin
This map shows the geographic impact of Ronggui Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronggui Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronggui Lin more than expected).
Fields of papers citing papers by Ronggui Lin
This network shows the impact of papers produced by Ronggui Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronggui Lin. The network helps show where Ronggui Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ronggui Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 47 | |
| 2 | 2020 | 47 | |
| 3 | 2022 | 30 | |
| 4 | 2020 | 17 | |
| 5 | 2020 | 14 | |
| 6 | 2019 | 12 | |
| 7 | 2021 | 11 | |
| 8 | 2020 | 10 | |
| 9 | 2021 | 10 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 8 | |
| 12 | 2023 | 6 | |
| 13 | 2024 | 6 | |
| 14 | 2024 | 6 | |
| 15 | 2020 | 5 | |
| 16 | 2023 | 4 | |
| 17 | 2021 | 3 | |
| 18 | 2022 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2021 | 3 |
About Ronggui Lin
Ronggui Lin is a scholar working on Oncology, Surgery, Molecular Biology, Biomedical Engineering and Gastroenterology, having authored 34 papers that have together received 273 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (18 papers), Hernia repair and management (5 papers), Pancreatitis Pathology and Treatment (3 papers), Nanoplatforms for cancer theranostics (3 papers), Cancer Genomics and Diagnostics (2 papers), Gastrointestinal Tumor Research and Treatment (2 papers), PI3K/AKT/mTOR signaling in cancer (1 paper) and Inflammatory Biomarkers in Disease Prognosis (1 paper). The work is most often cited by research in Oncology (111 citations), Immunology (51 citations), Neurology (16 citations), Surgery (71 citations) and Gastroenterology (7 citations). Ronggui Lin has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Heguang Huang, Xianchao Lin, Fengchun Lu, Yu Pan, Fei Chen, Wen Shi, Yuanyuan Yang, Yuanyuan Zhou, Xunbin Yu and Xingxing Yu. Their work appears in journals such as Langenbeck s Archives of Surgery, Cancer Letters, BMC Surgery, World Journal of Surgical Oncology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.